AI Tokens
Stock Analysis on Net

Bed Bath & Beyond Inc. (NASDAQ:BBBY)

This company has been moved to the archive! The financial data has not been updated since September 30, 2022.

Income Statement
Quarterly Data

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Bed Bath & Beyond Inc., consolidated income statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Aug 27, 2022 May 28, 2022 Feb 26, 2022 Nov 27, 2021 Aug 28, 2021 May 29, 2021 Feb 27, 2021 Nov 28, 2020 Aug 29, 2020 May 30, 2020 Feb 29, 2020 Nov 30, 2019 Aug 31, 2019 Jun 1, 2019 Mar 2, 2019 Dec 1, 2018 Sep 1, 2018 Jun 2, 2018 Mar 3, 2018 Nov 25, 2017 Aug 26, 2017 May 27, 2017 Feb 25, 2017 Nov 26, 2016 Aug 27, 2016 May 28, 2016
Net sales 1,437,018 1,463,418 2,051,396 1,877,874 1,984,696 1,953,812 2,619,141 2,618,472 2,687,968 1,307,447 3,106,822 2,759,322 2,719,447 2,572,989 3,307,881 3,032,231 2,935,018 2,753,667 3,716,264 2,954,539 2,936,357 2,742,141 3,533,954 2,955,484 2,988,235 2,738,084
Cost of sales (1,038,756) (1,114,106) (1,471,588) (1,208,954) (1,383,627) (1,320,118) (1,793,653) (1,661,905) (1,700,431) (958,958) (2,093,166) (1,845,485) (1,992,459) (1,685,810) (2,161,020) (2,028,521) (1,946,457) (1,788,819) (2,382,984) (1,913,478) (1,867,798) (1,742,026) (2,190,863) (1,862,710) (1,871,342) (1,714,492)
Gross profit 398,262 349,312 579,808 668,920 601,069 633,694 825,488 956,567 987,537 348,489 1,013,656 913,837 726,988 887,179 1,146,861 1,003,710 988,561 964,848 1,333,280 1,041,061 1,068,559 1,000,115 1,343,091 1,092,774 1,116,893 1,023,592
Selling, general and administrative expenses (634,877) (637,508) (682,605) (697,953) (652,972) (658,762) (759,248) (890,740) (850,218) (724,157) (1,027,041) (931,814) (880,889) (892,754) (933,691) (954,197) (909,703) (883,619) (996,177) (932,701) (899,712) (853,104) (913,163) (881,491) (835,920) (810,566)
Impairments (55,518) (26,699) (18,059) (1,759) (7,584) (9,129) 45,093 (57,997) (29,176) (85,261) (67,821) (11,781) (28,357) (401,267) (509,905) — — — — — — — — — — —
Restructuring and transformation initiative expenses (54,069) (24,263) (44,625) (41,219) (24,495) (33,686) (58,304) (16,770) (27,128) — — — — — — — — — — — — — — — — —
Gain (loss) on sale of businesses — — — (14,100) (132) (3,989) (76,681) (113,909) 189,528 — — — — — — — — — — — — — — — — —
Operating profit (loss) (346,202) (339,158) (165,481) (86,111) (84,114) (71,872) (23,652) (122,849) 270,543 (460,929) (81,206) (29,758) (182,258) (406,842) (296,735) 49,513 78,858 81,229 337,103 108,360 168,847 147,011 429,928 211,283 280,973 213,026
Interest expense, net (18,603) (16,448) (16,809) (15,772) (16,121) (16,000) (18,566) (17,805) (23,371) (17,171) (15,370) (17,179) (16,342) (15,898) (15,440) (22,691) (14,611) (16,732) (16,294) (13,621) (19,166) (16,580) (16,787) (18,254) (18,199) (16,315)
Gain (loss) on extinguishment of debt — — — — (111) (265) — — 77,038 — — — — — — — — — — — — — — — — —
Earnings (loss) before (provision) benefit from income taxes (364,805) (355,606) (182,290) (101,883) (100,346) (88,137) (42,218) (140,654) 324,210 (478,100) (96,576) (46,937) (198,600) (422,740) (312,175) 26,822 64,247 64,497 320,809 94,739 149,681 130,431 413,141 193,029 262,774 196,711
(Provision) benefit for income taxes (1,354) (2,060) 23,185 (174,546) 27,131 37,263 51,277 65,213 (106,310) 175,809 31,162 8,385 59,835 51,655 58,382 (2,468) (15,608) (20,921) (126,765) (33,438) (55,451) (55,148) (144,411) (66,605) (95,439) (74,092)
Net earnings (loss) (366,159) (357,666) (159,105) (276,429) (73,215) (50,874) 9,059 (75,441) 217,900 (302,291) (65,414) (38,552) (138,765) (371,085) (253,793) 24,354 48,639 43,576 194,044 61,301 94,230 75,283 268,730 126,424 167,335 122,619

Based on: 10-Q (reporting date: 2022-08-27), 10-Q (reporting date: 2022-05-28), 10-K (reporting date: 2022-02-26), 10-Q (reporting date: 2021-11-27), 10-Q (reporting date: 2021-08-28), 10-Q (reporting date: 2021-05-29), 10-K (reporting date: 2021-02-27), 10-Q (reporting date: 2020-11-28), 10-Q (reporting date: 2020-08-29), 10-Q (reporting date: 2020-05-30), 10-K (reporting date: 2020-02-29), 10-Q (reporting date: 2019-11-30), 10-Q (reporting date: 2019-08-31), 10-Q (reporting date: 2019-06-01), 10-K (reporting date: 2019-03-02), 10-Q (reporting date: 2018-12-01), 10-Q (reporting date: 2018-09-01), 10-Q (reporting date: 2018-06-02), 10-K (reporting date: 2018-03-03), 10-Q (reporting date: 2017-11-25), 10-Q (reporting date: 2017-08-26), 10-Q (reporting date: 2017-05-27), 10-K (reporting date: 2017-02-25), 10-Q (reporting date: 2016-11-26), 10-Q (reporting date: 2016-08-27), 10-Q (reporting date: 2016-05-28).


The financial performance of the entity demonstrates a transition from consistent profitability between 2016 and 2018 to a period of significant instability and sustained losses from 2019 through August 2022. A systemic decline in revenue, coupled with substantial non-recurring charges, has severely eroded the organization's earnings capacity.

Revenue Trends
Net sales remained relatively stable between 2016 and 2018, typically fluctuating between 2.7 billion and 3.7 billion US dollars per quarter. However, a marked downward trajectory began in 2019. A critical volatility point occurred in May 2020, where sales dropped to 1.3 billion US dollars, followed by a partial recovery. Despite this, a secular decline is evident from 2021 onward, with sales falling to 1.4 billion US dollars by August 2022, representing a significant contraction in market reach or demand.
Gross Profitability and Margin Compression
Gross profit followed a similar pattern to net sales, peaking at 1.3 billion US dollars in early 2017 and early 2018. A sharp deterioration in gross profit is observed starting in 2019. While cost of sales decreased in absolute terms as revenue fell, the gross profit margin experienced compression. By August 2022, gross profit had fallen to approximately 398 million US dollars, indicating a reduced ability to maintain pricing power or manage procurement costs relative to sales volume.
Operating Expenses and Cost Management
Selling, general, and administrative (SG&A) expenses remained largely stagnant between 800 million and 900 million US dollars during the initial period of stability. As revenue declined, SG&A expenses were gradually reduced, dropping to approximately 634 million US dollars by August 2022. This suggests an attempt at cost-containment; however, the reduction in overhead was insufficient to offset the rapid loss of gross profit, leading to widening operating losses.
Non-Recurring Charges and Impairments
The financial profile shifted dramatically in March 2019 with the introduction of substantial impairment charges, starting with a 509 million US dollar loss. Frequent impairment and restructuring expenses became a recurring feature of the income statement from 2019 through 2022. Restructuring and transformation initiative expenses became prominent in late 2020, consistently draining tens of millions of dollars per quarter, reflecting a period of distressed organizational realignment.
Net Earnings and Bottom-Line Performance
Operating profit transitioned from positive territory in 2016-2018 to chronic deficits. A brief return to operating profitability in August 2020 is attributable to a 189 million US dollar gain on the sale of businesses rather than core operational improvement. The final quarters analyzed show accelerating net losses, culminating in a loss of 366 million US dollars in August 2022. The impact of tax benefits provided intermittent relief in some quarters, but they were unable to mitigate the underlying operational decline.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?